| __timestamp | Arrowhead Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 580006000 |
| Thursday, January 1, 2015 | 382000 | 676585000 |
| Friday, January 1, 2016 | 158333 | 778966000 |
| Sunday, January 1, 2017 | 31407709 | 671251000 |
| Monday, January 1, 2018 | 16142321 | 463508000 |
| Tuesday, January 1, 2019 | 168795577 | 445724000 |
| Wednesday, January 1, 2020 | 87992066 | 399725000 |
| Friday, January 1, 2021 | 138287000 | 296656000 |
| Saturday, January 1, 2022 | 232810000 | 293122000 |
| Sunday, January 1, 2023 | 240735000 | 268323000 |
| Monday, January 1, 2024 | 3551000 | 304979000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, understanding financial health is crucial. This analysis compares the gross profit trajectories of Arrowhead Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. over a decade, from 2014 to 2024.
Arrowhead Pharmaceuticals, Inc. has shown a remarkable growth trajectory, with gross profits surging from a modest $175,000 in 2014 to an impressive $240 million by 2023. This represents a staggering increase of over 137,000%. However, 2024 shows a significant drop, indicating potential challenges ahead.
Conversely, Taro Pharmaceutical Industries Ltd. started strong with a gross profit of $580 million in 2014, peaking at $779 million in 2016. Since then, a steady decline has been observed, with profits falling to $268 million by 2023, a decrease of about 54% from its peak.
These trends highlight the dynamic nature of the pharmaceutical industry, where innovation and market conditions can dramatically impact financial outcomes.
Gross Profit Analysis: Comparing Novo Nordisk A/S and Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Amgen Inc. and Taro Pharmaceutical Industries Ltd.
Vertex Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Regeneron Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Genmab A/S and Arrowhead Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Catalent, Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Key Insights on Gross Profit: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Grifols, S.A. or Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. Trends
HUTCHMED (China) Limited vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown